DataMetrex Management Announces Strategic Plan
Datametrex AI (DTMXF) has announced a strategic restructuring plan focusing on healthcare and AI businesses. The company plans to expand its healthcare operations through M&A, targeting clinic acquisitions to provide family medicine, walk-in examinations, and specialist care. The expansion includes wellness services like IV therapy, Botox, and laser treatments.
As part of its 'deep and narrow' strategy, Datametrex will discontinue non-core operations in pharmacy and mobile gaming. The company reports strong cash flows from its AI service operations and aims to optimize AI solutions while exploring new partnerships.
A significant corporate restructuring is planned to split the company into two separate entities, focusing independently on healthcare and AI operations, aimed at enhancing operational efficiency and shareholder value.
Datametrex AI (DTMXF) ha annunciato un piano di ristrutturazione strategica focalizzato sul settore sanitario e sulle attività legate all'IA. L'azienda prevede di espandere le sue operazioni sanitarie attraverso fusioni e acquisizioni, puntando all'acquisizione di cliniche per fornire medicina di famiglia, visite senza appuntamento e cure specialistiche. L'espansione include servizi di benessere come terapia IV, Botox e trattamenti laser.
Come parte della sua strategia 'profonda e ristretta', Datametrex interromperà le operazioni non core nel settore farmaceutico e nei giochi mobili. L'azienda riporta flussi di cassa solidi dalle sue operazioni di servizi IA e mira a ottimizzare le soluzioni IA esplorando nuove partnership.
È prevista una significativa ristrutturazione aziendale per dividere l'azienda in due entità separate, focalizzandosi in modo indipendente sulle operazioni sanitarie e sull'IA, con l'obiettivo di migliorare l'efficienza operativa e il valore per gli azionisti.
Datametrex AI (DTMXF) ha anunciado un plan de reestructuración estratégica centrado en el sector salud y en los negocios de IA. La empresa planea expandir sus operaciones en salud a través de fusiones y adquisiciones, apuntando a la adquisición de clínicas para proporcionar medicina familiar, exámenes sin cita y atención especializada. La expansión incluye servicios de bienestar como terapia IV, Botox y tratamientos láser.
Como parte de su estrategia 'profunda y estrecha', Datametrex descontinuará operaciones no centrales en farmacia y juegos móviles. La empresa reporta flujos de efectivo sólidos de sus operaciones de servicios de IA y busca optimizar soluciones de IA mientras explora nuevas asociaciones.
Se planea una reestructuración corporativa significativa para dividir la empresa en dos entidades separadas, enfocándose de manera independiente en las operaciones de salud y de IA, con el objetivo de mejorar la eficiencia operativa y el valor para los accionistas.
Datametrex AI (DTMXF)는 의료 및 AI 비즈니스에 집중하는 전략적 구조조정 계획을 발표했습니다. 회사는 의료 운영을 확장할 계획이며, 가족 의학, 방문 진료 및 전문 치료를 제공하기 위해 클리닉 인수를 목표로 하고 있습니다. 확장에는 IV 요법, 보톡스 및 레이저 치료와 같은 웰니스 서비스가 포함됩니다.
'깊고 좁은' 전략의 일환으로, Datametrex는 비핵심 운영을 중단할 것입니다. 회사는 AI 서비스 운영에서 강력한 현금 흐름을 보고하며, 새로운 파트너십을 탐색하면서 AI 솔루션을 최적화하는 것을 목표로 하고 있습니다.
회사를 두 개의 별도 법인으로 분할하는 중대한 기업 구조조정이 계획되어 있으며, 의료 및 AI 운영에 독립적으로 집중하여 운영 효율성과 주주 가치를 향상시키는 것을 목표로 하고 있습니다.
Datametrex AI (DTMXF) a annoncé un plan de restructuration stratégique axé sur le secteur de la santé et les activités d'IA. L'entreprise prévoit d'élargir ses opérations dans le domaine de la santé par le biais de fusions et d'acquisitions, visant à acquérir des cliniques pour fournir des soins de médecine familiale, des examens sans rendez-vous et des soins spécialisés. L'expansion inclut des services de bien-être tels que la thérapie IV, le Botox et les traitements au laser.
Dans le cadre de sa stratégie 'profonde et étroite', Datametrex cessera les opérations non essentielles dans le secteur pharmaceutique et les jeux mobiles. L'entreprise rapporte des flux de trésorerie solides provenant de ses opérations de services d'IA et vise à optimiser les solutions d'IA tout en explorant de nouveaux partenariats.
Une restructuration d'entreprise significative est prévue pour diviser l'entreprise en deux entités distinctes, se concentrant indépendamment sur les opérations de santé et d'IA, dans le but d'améliorer l'efficacité opérationnelle et la valeur pour les actionnaires.
Datametrex AI (DTMXF) hat einen strategischen Restrukturierungsplan angekündigt, der sich auf den Gesundheits- und KI-Sektor konzentriert. Das Unternehmen plant, seine Gesundheitsoperationen zu erweitern durch Fusionen und Übernahmen, wobei der Fokus auf dem Erwerb von Kliniken liegt, um Familienmedizin, Sprechstunden ohne Termin und Facharztversorgung anzubieten. Die Expansion umfasst Wellness-Dienstleistungen wie IV-Therapie, Botox und Laserbehandlungen.
Im Rahmen seiner 'tiefen und engen' Strategie wird Datametrex nicht zum Kerngeschäft gehörende Operationen einstellen im Bereich Pharmazie und mobiles Gaming. Das Unternehmen berichtet von starken Cashflows aus seinen KI-Dienstleistungen und zielt darauf ab, KI-Lösungen zu optimieren, während es neue Partnerschaften erkundet.
Eine bedeutende Unternehmensrestrukturierung ist geplant, um das Unternehmen in zwei separate Einheiten zu spalten, die sich unabhängig auf Gesundheits- und KI-Operationen konzentrieren, um die Betriebseffizienz und den Wert für die Aktionäre zu steigern.
- Strong cash flows reported from AI operations
- Strategic consolidation through M&A to reduce overhead costs
- Expansion of healthcare services portfolio
- Corporate split to enhance operational efficiency
- Discontinuation of pharmacy and mobile gaming divisions
- Significant restructuring costs expected
- Execution risk in M&A strategy
TORONTO, ON / ACCESS Newswire / February 27, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to provide an update on its strategic direction with its commitment to focusing on healthcare and AI businesses.
As part of its growth initiatives, Datametrex plans to bolster its healthcare sector by expanding its clinic operations to meet a broader range of healthcare needs, including family medicine, walk-in examinations, and care by a specialist. The expansion will take place primarily via Mergers and Acquisitions (M&A), which the Company has identified numerous targets to roll up, and consolidate operations to lower the overhead costs and boost profits. The Company's clinic services will also be strengthened with wellness offerings, including IV therapy, Botox, and laser treatments. In alignment with this expansion, the Company plans to acquire additional clinics and their associated properties.
The Company has decided to wind down its non-core business, such as pharmacy and mobile gaming, to focus solely on healthcare and AI, as part of its deep and narrow strategy.
As part of this strategy, the Company will initiate industry consolidation through the acquisition and integration of multiple clinics and properties. This approach aims to strengthen the Company's portfolio by expanding its network of healthcare facilities.
Datametrex will continue to focus on its AI business. It is pleased to announce that the cash flows from AI service operations have remained strong through the Company's active and strategic management and customer acquisition. The Company is committed to further expanding its market presence, optimizing its AI solutions, and exploring new partnerships to drive sustainable growth in this sector.
Looking ahead, Datametrex intends to pursue a corporate restructuring plan that will split the Company into two entities, allowing for a distinct focus on healthcare and AI business operations. This initiative is expected to enhance operational efficiency and create greater value for shareholders.
Paul Haber, CEO of Datametrex, commented, "Our company is dedicated to strengthening our focus on the healthcare and AI business and ensuring that our upcoming corporate restructuring enhances efficiency and aligns with the best interests of our shareholders. We appreciate your continued support and look forward to the next phase of our growth."
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our Company website.
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
info@datametrex.com
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original press release on ACCESS Newswire
FAQ
What is Datametrex's (DTMXF) new strategic focus for 2025?
How is DTMXF planning to expand its healthcare operations?
What is the planned corporate restructuring for Datametrex (DTMXF)?
How is Datametrex's AI business performing according to the announcement?
